Literature DB >> 6183593

High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies.

B S Prabhakar, M V Haspel, P R McClintock, A L Notkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6183593     DOI： 10.1038/300374a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  19 in total

1.  Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies.

Authors:  S Yagi; D Schnurr; J Lin
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Impact on routine diagnosis of echovirus infections of intratypic differentiation and antigenic variation in echovirus type 25 studied by using monoclonal antibodies.

Authors:  H Peigue-Lafeuille; F Fuchs; F Gharabaghi; M Chambon; M Aymard
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

3.  Comparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehyde.

Authors:  M Chambon; C Jallat-Archimbaud; J L Bailly; J M Gourgand; F Charbonne; C Henquell; F Fuchs; H Peigue-Lafeuille
Journal:  Appl Environ Microbiol       Date:  1997-08       Impact factor: 4.792

4.  Identification of a putative shared epitope between Coxsackie virus B4 and alpha cardiac myosin heavy chain.

Authors:  K W Beisel; J Srinivasappa; B S Prabhakar
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

5.  Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates.

Authors:  T M Szopa; T Ward; D M Dronfield; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

Review 6.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Direct measurement of the poliovirus RNA polymerase error frequency in vitro.

Authors:  C D Ward; M A Stokes; J B Flanegan
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

8.  Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues.

Authors:  J Srinivasappa; J Saegusa; B S Prabhakar; M K Gentry; M J Buchmeier; T J Wiktor; H Koprowski; M B Oldstone; A L Notkins
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

9.  The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children--no evidence of increased antibody frequency.

Authors:  T Tuvemo; G Dahlquist; G Frisk; L Blom; G Friman; M Landin-Olsson; H Diderholm
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

10.  Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells.

Authors:  R Kandolf; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.